Bimodal fuzzy analytic hierarchy process (BFAHP) for coronary heart disease risk assessment

Farnaz Sabahi1

  • 1Soft Computing Laboratory, Faculty of Electrical and Computer Engineering, Urmia University, Urmia, Iran.

Insights

A new Bimodal Fuzzy Analytic Hierarchy Process (BFAHP) improves coronary heart disease (CHD) risk assessment by incorporating fuzzy validity and probability, achieving over 85% prediction accuracy. This method enhances confidence in results, especially with incomplete medical data.

Area of Science:

  • Medical Decision Making
  • Health Informatics
  • Biostatistics

Background:

  • Coronary heart disease (CHD) risk assessment is crucial but complex due to stochastic and uncertain variables.
  • Traditional methods struggle with the inherent uncertainty in medical decision-making.
  • Fuzzy Analytic Hierarchy Process (FAHP) is a popular methodology for handling uncertainty in multi-criteria decision-making (MCDM).

Purpose of the Study:

  • To introduce a novel Bimodal Fuzzy Analytic Hierarchy Process (BFAHP) for enhanced CHD risk assessment.
  • To augment fuzzy numbers with probability and validity to better manage uncertainty in risk assessment.
  • To improve the accuracy and confidence of CHD risk prediction, particularly with incomplete information.

Main Methods:

  • Developed BFAHP by incorporating fuzzy validity (aggregated expert knowledge) and fuzzy probability (Bayesian formulation).
  • Constructed a reciprocal comparison matrix using fuzzy validities and probabilities.
  • Applied BFAHP to a real dataset of 152 patients for CHD risk assessment, evaluating prediction accuracy.

Main Results:

  • The BFAHP approach achieved a high accuracy rate exceeding 85% for correct CHD risk prediction.
  • Incorporating fuzzy validity increased confidence in the assessment results, proving clinically useful with incomplete data.
  • Identified diastolic blood pressure in men and high-density lipoprotein in women as key risk factors for CHD.

Conclusions:

  • BFAHP offers a robust and accurate method for medical risk assessment, outperforming existing approaches.
  • The inclusion of fuzzy validity significantly enhances the reliability of risk predictions in uncertain medical scenarios.
  • The findings provide valuable insights into specific risk factors for CHD, aiding targeted prevention strategies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
558
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734